Underutilized Fuel: Angiotensin II for Vasoplegia in the Heart Failure Patient Population

J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3843. doi: 10.1053/j.jvca.2021.04.005. Epub 2021 Apr 10.

Authors

Amit Alam¹, Daniel Burkhoff², Daniel H Enter³, Rita Jermyn⁴

Affiliations

¹ Baylor University Medical Center, Dallas, TX; Texas A&M University College of Medicine, Bryan, TX. Electronic address: Amit.Alam@bswhealth.org.
² Columbia University, Manhattan, NY.
³ Baylor University Medical Center, Dallas, TX.
⁴ St. Francis Hospital, Roslyn, NY.

PMID: 33975791
DOI: 10.1053/j.jvca.2021.04.005

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiotensin II
Heart Failure* / drug therapy
Humans
Vasoplegia* / diagnosis
Vasoplegia* / drug therapy

Substances

Angiotensin II